Imaging in clinical trials has seen tremendous growth over the past two decades and is increasingly used as the primary endpoint for some related trials.However, variability across images collected (and subsequent analysis) inevitably leads to larger sample sizes, longer timelines and bigger budgets, putting added pressure on study teams to minimize these risks.
Stop by booth 79 and learn how ERT identifies trial risks before they become problems to help clinical trial sponsors bring clinical treatments to patients quickly ─ and with confidence.
And, be sure to attend, ‘Overcoming Imaging Challenges:Strategies to Minimize Risk and Generate Higher-Quality Data,’ presented by ERT’s Amit Vasanji at 12:00 on Wednesday, February 21. He’ll share practical real-world examples and strategies on how to successfully:
- Enable more objective assessments unencumbered by reader bias
- Streamline regulatory compliance and speed approval timelines
- Achieve greater data consistency and complete data transparency
- Reduce rework and drive operational efficiencies
Can’t attend the conference? Read ‘Picture This: Managing the Entire Lifecycle of Clinical Trial Images in a Single Tool’ for more information on how the right technology can dramatically improve compliance, efficiency, and visibility in trials involving imaging.